Respicardia's remedē® System Receives FDA Approval
MINNETONKA, Minn., Oct. 10, 2017 /PRNewswire/ -- Respicardia, Inc., a private medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) approval of its remedē® System, a transvenous implantable neurostimulation system that stimulates the phrenic...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]es-fda-approval-300533881.html
